U.S., Feb. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07398703) titled 'Extended vs. Intermittent Beta-Lactam Infusion in ICU Sepsis' on Sept. 28, 2025.
Brief Summary: This observational study compares extended versus intermittent beta-lactam infusion in sepsis patients, assessing survival, clinical cure rates, and practical ICU challenges. The findings will guide optimal antibiotic protocols, potentially improving sepsis outcomes through precision dosing strategies.
Study Start Date: Oct., 2026
Study Type: OBSERVATIONAL
Condition:
Sepsis
Septic Shock
Intervention:
DRUG: Extended beta-lactam antibiotics
Group A will be receiving extended infusion of beta-lactam antibiotic over 4 hours.
DRUG: Int...